Nephrocare Health Services Limited share price
Nephrocare Health Services Limited provides dialysis healthcare services through a chain of kidney care clinics and dialysis centers in India, Uzbekistan, Nepal, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. The company was incorporated in 2009 and is based in Hyderabad, India.Read more
- Market Cap₹ 6,178 Cr.
- Current Price₹ 614.35
- High / Low₹ 782 / 446
- Stock P/E72.4
- Book Value₹ 111
- Dividend Yield0.00 %
- ROCE13.3 %
- ROE9.00 %
- Face Value₹ 2.0
More figures (10)
- EPS (TTM)₹ 8.48
- Price / Book5.52
- OPM14.0 %
- Debt / Equity0.07
- Sales growth (4Y)33.9 %
- Profit growth (4Y)—
- Promoter holding49.3 %
- EV / EBITDA25.4
- Beta—
- All-time high₹ 782
Price chart
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| NEPHROPLUS | -16.44% | -3.37% | +8.30% | +31.08% | — | — | — |
| Nifty 50 | -0.31% | -3.85% | -4.34% | -11.42% | -9.53% | +5.46% | +4.76% |
Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.
Quick take
- Nephrocare Health Services Limited is in the Medical Care Facilities industry (Healthcare), with a market value of ₹6,178 crore.
- It trades at 72.4 times its last 12 months' earnings and 5.5 times book value.
- Revenue grew 33.9% a year over the last 4 years.
- Return on equity was 9.0% and return on capital employed 13.3% in the latest year.
- Debt was 0.07 times shareholders' equity.
- The share price is 21.4% below its 52-week high.
- Promoters and insiders hold about 49.3%; institutions about 39.8%.
Pros
AI- Company is almost debt-free (debt is 0.07 times equity).
Cons
AI- Promoter holding has fallen by 5.54 points over 4 quarters, to 58.31%.
- The company has not paid a dividend recently.
Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.
AI analysis
Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.
About Nephrocare Health Services Limited
Nephrocare Health Services Limited provides dialysis healthcare services through a chain of kidney care clinics and dialysis centers in India, Uzbekistan, Nepal, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. The company was incorporated in 2009 and is based in Hyderabad, India.
- Employees
- 2,294
- Head office
- Hyderabad
- NSE industry
- Healthcare
Peer comparison
HealthcareHealthcareMedical Care Facilities
Part ofNifty Microcap 250
| S.No. | Company | CMP ₹ | P/E | Mar Cap ₹ Cr | Div Yld % | NP Qtr ₹ Cr | Qtr Profit Var % | Sales Qtr ₹ Cr | Qtr Sales Var % | ROCE % | ROE % | P/B | OPM % | Debt / Eq | Prom. Hold. % | Sales ₹ Cr | Sales Var 3Yrs % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Nephrocare Health Services | 614.35 | 72.4 | 6,178 | 0.00 | 32 | — | 282 | — | 13.3 | 9.0 | 5.52 | 14.0 | 0.07 | 49.30 | 999 | 33.9 |
| 2. | Apollo Hospitals Enterprise | 7,890.00 | 54.3 | 1,13,446 | 0.25 | 581 | 49.05 | 7,044 | 25.95 | 19.2 | 21.9 | 11.97 | 11.7 | 0.90 | 28.39 | 24,911 | 14.8 |
| 3. | Max Healthcare Institute | 846.00 | 56.7 | 82,342 | 0.23 | 323 | 4.87 | 2,366 | 16.70 | 12.6 | 14.3 | 7.66 | 22.8 | 0.32 | 28.20 | 8,225 | 22.4 |
| 4. | Aster DM Quality Care | 674.35 | 109.3 | 58,781 | 0.44 | 29 | -68.70 | 1,311 | 21.60 | 9.4 | 9.7 | 7.59 | 14.2 | 0.49 | 64.26 | 4,643 | 15.7 |
| 5. | Fortis Healthcare | 736.50 | 53.1 | 55,603 | 0.13 | 266 | 2.35 | 2,545 | 17.46 | 11.9 | 11.1 | 5.62 | 17.8 | 0.35 | 35.19 | 9,048 | 13.3 |
| 6. | Narayana Hrudayalaya | 1,719.40 | 42.5 | 34,921 | 0.26 | 207 | 5.35 | 2,684 | 78.05 | 11.4 | 19.7 | 7.70 | 15.5 | 1.29 | 67.23 | 7,858 | 20.5 |
| 7. | Global Health | 1,240.00 | 60.0 | 33,322 | 0.04 | 159 | -0.18 | 1,304 | 26.50 | 15.0 | 15.1 | 8.41 | 16.8 | 0.30 | 66.39 | 4,318 | 17.2 |
| 8. | Krishna Institute of Medical Sciences | 685.60 | 134.4 | 28,796 | 0.00 | 42 | -47.20 | 1,180 | 35.33 | 8.1 | 11.0 | 12.21 | 13.8 | 1.89 | 41.74 | 3,872 | 21.3 |
| 9. | Rainbow Children's Medicare | 1,248.90 | 44.4 | 12,634 | 0.28 | 63 | 16.23 | 470 | 33.17 | 16.8 | 17.9 | 7.69 | 23.7 | 0.54 | 52.29 | 1,703 | 13.1 |
| 10. | Jeena Sikho Lifecare | 388.30 | 20.5 | 4,828 | 1.16 | 66 | 28.57 | 224 | 28.76 | 54.5 | 61.3 | 10.34 | 38.2 | 0.27 | 72.48 | 799 | 57.7 |
| Median: 11 Co. | 791.25 | 54.3 | 33,322 | 0.23 | 112 | 4.87 | 1,307 | 26.50 | 13.0 | 15.1 | 7.70 | 16.8 | 0.42 | 50.80 | 4,481 | 20.5 |
Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.
Quarterly Results
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.
Profit & Loss
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Projection — your assumptions
Starts from the last four reported quarters (TTM) and applies the figures you enter; growth is pre-filled with the company's own past sales growth. This is a what-if calculator for illustration, not a forecast, estimate or recommendation.
Related party transactions
Related-party transactions are dealings with promoters, directors, subsidiaries and associates. Companies disclose them to the exchanges every half-year and in detail in the notes to their annual report.
No separate related-party filing among the recent announcements of the company.
Full details: notes to the Financial Year 2026 annual report (related party disclosures).
| ₹ Cr | Mar 2026 |
|---|---|
| Sales | 999 |
| 772 | |
| Material Cost % | 23% |
| Employee Cost % | 17% |
| Other Expenses % | 37% |
| Operating Profit | 227 |
| OPM % | 23% |
| Other Income | 25 |
| Interest | 60 |
| Depreciation | 91 |
| Profit before tax | 101 |
| 21% | |
| Current tax | 36 |
| Deferred tax | -15 |
| 77 | |
| Profit from associates | -3 |
| Profit to shareholders | 77 |
| EPS in Rs | 8.48 |
Return on Equity
- 4 Years:
- 7%
- Last Year:
- 9%
| ₹ Cr | Mar 2026 |
|---|---|
| Sales | 630 |
| 542 | |
| Material Cost % | 26% |
| Employee Cost % | 19% |
| Other Expenses % | 41% |
| Operating Profit | 88 |
| OPM % | 14% |
| Other Income | 15 |
| Interest | 50 |
| Depreciation | 58 |
| Profit before tax | -4 |
| Net Profit | -8 |
| EPS in Rs | -0.89 |
Return on Equity
- 4 Years:
- 7%
- Last Year:
- 9%
Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.
Balance Sheet
Consolidated figures in ₹ crore, as at 31 March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 20 |
| Reserves | 387 | 412 | 582 | 1,096 |
| 214 | 268 | 258 | 80 | |
| Long term borrowings | 81 | 123 | 96 | 0 |
| Short term borrowings | 115 | 120 | 130 | 23 |
| 64 | 124 | 155 | 275 | |
| Trade payables | 43 | 71 | 113 | 143 |
| Current liabilities | 175 | 243 | 284 | 299 |
| Total Liabilities | 666 | 806 | 996 | 1,471 |
| 253 | 306 | 334 | 415 | |
| Gross block | 397 | 511 | 610 | 726 |
| Accumulated depreciation | 144 | 205 | 276 | 311 |
| Goodwill & intangibles | 22 | 52 | 72 | 121 |
| CWIP | 33 | 2 | 10 | 18 |
| 381 | 498 | 652 | 1,038 | |
| Inventories | 26 | 26 | 27 | 33 |
| Trade receivables | 159 | 203 | 266 | 317 |
| Cash & equivalents | 13 | 61 | 126 | 124 |
| Current assets | 324 | 390 | 545 | 839 |
| Total Assets | 666 | 806 | 996 | 1,471 |
Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.
Cash Flows
Consolidated figures in ₹ crore, financial years ending March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 11 | 72 | 135 | 233 | |
| Profit for the year | -12 | 35 | 67 | 77 |
| Working capital changes | -53 | -33 | -44 | -6 |
| Direct taxes paid | 5 | -8 | -1 | -27 |
| -78 | -51 | -125 | -410 | |
| Fixed assets purchased | -74 | -80 | -101 | -119 |
| Fixed assets sold | 0 | |||
| Investments purchased | -5 | -151 | -353 | |
| Investments sold | 46 | 156 | 207 | |
| 60 | 27 | 54 | 157 | |
| Proceeds from borrowings | 101 | 74 | 8 | |
| Repayment of borrowings | -20 | -25 | -25 | -115 |
| Interest paid | -16 | -17 | -19 | -18 |
| Net Cash Flow | -7 | 48 | 65 | -21 |
| Free Cash Flow | -62 | -8 | 35 | 113 |
Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.
Ratios
| Ratio | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROE | — | -3.0% | 8.8% | 13.4% | 9.0% |
| ROCE | — | 1.2% | 9.3% | 14.9% | 13.3% |
| Operating margin | — | 0.9% | 9.9% | 13.2% | 14.0% |
| Net margin | — | -2.8% | 6.5% | 9.0% | 7.7% |
| Debt / equity | — | 0.55 | 0.65 | 0.44 | 0.07 |
| Current ratio | — | 1.86 | 1.61 | 1.92 | 2.80 |
| Debtor days | — | 140 | 137 | 130 | 116 |
| Inventory days | — | 43 | 33 | 28 | 29 |
| Days payable | — | 71 | 91 | 117 | 125 |
| Cash conversion cycle | — | 112 | 79 | 41 | 20 |
| Working capital days | — | 132 | 100 | 128 | 198 |
Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.
Shareholding Pattern
Numbers in percentages · as filed with NSE each quarter
- Promoters 58.31%
- FIIs 11.73%
- DIIs 8.11%
- Public 21.85%
| % | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Promoters | 63.85% | 63.85% | 63.85% | 58.31% |
| 9.30% | 9.94% | 8.78% | 11.73% | |
| Foreign portfolio investors (Cat. I) | 9.25% | 9.79% | 8.63% | 11.40% |
| Foreign portfolio investors (Cat. II) | 0.05% | 0.15% | 0.15% | 0.33% |
| 8.10% | 8.65% | 9.05% | 8.11% | |
| Mutual funds | 3.10% | 3.17% | 3.20% | 3.93% |
| Insurance companies | 1.52% | 1.50% | 1.21% | 0.45% |
| Alternative investment funds | 3.40% | 3.97% | 4.64% | 3.73% |
| 18.74% | 17.56% | 18.32% | 21.85% | |
| Retail (up to ₹2 lakh) | 3.97% | 3.13% | 3.75% | 6.41% |
| HNIs (above ₹2 lakh) | 1.95% | 1.95% | 1.94% | 2.29% |
| NRIs | 0.29% | 0.35% | 0.41% | 0.78% |
| Bodies corporate | 0.97% | 0.69% | 0.75% | 1.79% |
| No. of Shareholders | 67,416 | 43,409 | 44,091 | 56,735 |
Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.
Mutual funds & institutions holding Nephrocare Health Services
| Holder (above 1%) | Stake |
|---|---|
| 360 One Special Opportunities Fund - Series 9AIF | 1.30% |
| SBI HEALTHCARE OPPORTUNITIES FUNDMutual fund | 1.07% |
As named in the shareholding pattern for Sep 2026 filed with NSE; mutual funds together hold 3.93% of the company. Shareholders below 1% are not named in the filing.
Documents
Announcements
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Nephrocare Health Services Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 201807-Oct-2026
- Trading WindowNephrocare Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201525-Sep-2026
- Other RestructuringNephrocare Health Services Limited has informed the Exchange about Other Restructuring - Rationalisation and Consolidation of Company''s Step-down Subsidiaries in the Philippines …18-Sep-2026
- AgreementsNephrocare Health Services Limited has informed the Exchange about Agreements14-Sep-2026
- Options to purchase securitiesNephrocare Health Services Limited has informed the Exchange about Grant of Employee Stock Options under the NephroPlus Employee Stock Option Scheme 2026.03-Sep-2026
- AgreementsNephrocare Health Services Limited has informed the Exchange about Acquisition of 100% participatory interest in Dialysis Center Almaty LLP, Kazakhstan01-Sep-2026
- Pendency of Litigation(s)/dispute(s) or the outcome impacting the CompanyNephrocare Health Services Limited has informed the Exchange about Tax demand pursuant to tax audit.31-Aug-2026
- AgreementsNephrocare Health Services Limited has informed the Exchange about Agreements17-Aug-2026
- Shareholders meetingNephrocare Health Services Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 12, 2026. Further, the company has informed the Ex…13-Aug-2026
- AgreementsNephrocare Health Services Limited has informed the Exchange about Agreements13-Aug-2026
- Disclosure of material issueNephrocare Health Services Limited has informed regarding Disclosure of material issue regarding Clarification to disclosure under Reg 30 dated May 26, 2026 regarding incorporatio…12-Aug-2026
- Shareholders meetingNephrocare Health Services Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 12, 202612-Aug-2026
Annual reports
Credit ratings
Concalls & investor meets
- Analysts/Institutional Investor Meet/Con. Call UpdatesNephrocare Health Services Limited has informed the Exchange about Schedule of meet22-Sep-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesNephrocare Health Services Limited has informed the Exchange about Transcript19-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesNephrocare Health Services Limited has informed the Exchange about Schedule of meet13-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesNephrocare Health Services Limited has informed the Exchange about Link of Recording12-Aug-2026
- Investor PresentationNephrocare Health Services Limited has informed the Exchange about Investor Presentation11-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesNephrocare Health Services Limited has informed the Exchange about Schedule of meet10-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesNephrocare Health Services Limited has informed the Exchange about Schedule of meet24-Jul-2026
- General UpdatesNephrocare Health Services Limited has informed the Exchange about With reference to our letter dated May 26, 2026, please note that the Company's participation in the Analyst / I…17-Jun-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesNephrocare Health Services Limited has informed the Exchange about Schedule of meet11-Jun-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesNephrocare Health Services Limited has informed the Exchange about Transcript27-May-2026
Filings made by the company with NSE; documents open on NSE's website.
Key dates
- Ex-dividend date
- 1 Jan 1970
- Latest quarter
- 30 Jun 2026
- Financial year end
- 31 Mar 2026
Trade with our broking desk
Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.
Latest news
In the news
From the company (NSE)
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Nephrocare Health Services Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018NSE filing · 07-Oct-2026
- Trading WindowNephrocare Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015NSE filing · 25-Sep-2026
- Other RestructuringNephrocare Health Services Limited has informed the Exchange about Other Restructuring - Rationalisation and Consolidation of Company''s Step-down Subsidiaries in the Philippines …NSE filing · 18-Sep-2026
- AgreementsNephrocare Health Services Limited has informed the Exchange about AgreementsNSE filing · 14-Sep-2026
- Options to purchase securitiesNephrocare Health Services Limited has informed the Exchange about Grant of Employee Stock Options under the NephroPlus Employee Stock Option Scheme 2026.NSE filing · 03-Sep-2026
- AgreementsNephrocare Health Services Limited has informed the Exchange about Acquisition of 100% participatory interest in Dialysis Center Almaty LLP, KazakhstanNSE filing · 01-Sep-2026
- Pendency of Litigation(s)/dispute(s) or the outcome impacting the CompanyNephrocare Health Services Limited has informed the Exchange about Tax demand pursuant to tax audit.NSE filing · 31-Aug-2026
- AgreementsNephrocare Health Services Limited has informed the Exchange about AgreementsNSE filing · 17-Aug-2026
Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.
Questions about Nephrocare Health Services Limited
What is the share price of Nephrocare Health Services Limited today?
What is the market cap of Nephrocare Health Services Limited?
What is the P/E ratio of Nephrocare Health Services Limited?
Is Nephrocare Health Services Limited a good investment?
How can I buy Nephrocare Health Services Limited shares?
Have a question about this topic?
Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.
Book your free wealth consultation
- 100% free
- No obligation
- Reply within 2 hours
Request received!
Thank you for trusting Plenitude Connect. An expert will contact you shortly. Please check your inbox for details.